Cameron Taylor Nutt, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Atrioventricular Block | 1 | 2021 | 121 | 0.660 |
Why?
|
| Lost to Follow-Up | 1 | 2019 | 123 | 0.650 |
Why?
|
| Lyme Disease | 2 | 2023 | 630 | 0.620 |
Why?
|
| Syncope | 1 | 2021 | 428 | 0.590 |
Why?
|
| Epidemics | 2 | 2017 | 510 | 0.470 |
Why?
|
| Myocarditis | 1 | 2021 | 766 | 0.430 |
Why?
|
| Continuity of Patient Care | 1 | 2019 | 1066 | 0.410 |
Why?
|
| Rwanda | 16 | 2016 | 659 | 0.390 |
Why?
|
| Papillomavirus Vaccines | 3 | 2015 | 495 | 0.340 |
Why?
|
| Health Status Disparities | 1 | 2019 | 1830 | 0.300 |
Why?
|
| Physician-Patient Relations | 1 | 2019 | 3242 | 0.270 |
Why?
|
| Attitude of Health Personnel | 1 | 2019 | 3865 | 0.260 |
Why?
|
| Uterine Cervical Neoplasms | 3 | 2013 | 2003 | 0.260 |
Why?
|
| Health Services Accessibility | 4 | 2019 | 5397 | 0.250 |
Why?
|
| Healthcare Disparities | 3 | 2019 | 3388 | 0.250 |
Why?
|
| International Cooperation | 4 | 2016 | 1433 | 0.240 |
Why?
|
| Vaccination | 2 | 2015 | 3361 | 0.220 |
Why?
|
| Hemorrhagic Fever, Ebola | 2 | 2017 | 420 | 0.190 |
Why?
|
| Immunization Programs | 2 | 2015 | 268 | 0.190 |
Why?
|
| Cooperative Behavior | 4 | 2016 | 1500 | 0.180 |
Why?
|
| Papillomavirus Infections | 1 | 2011 | 1607 | 0.170 |
Why?
|
| Developing Countries | 4 | 2015 | 2868 | 0.160 |
Why?
|
| Adenosine Monophosphate | 1 | 2020 | 283 | 0.160 |
Why?
|
| Alanine | 1 | 2020 | 606 | 0.150 |
Why?
|
| Renal Insufficiency, Chronic | 2 | 2022 | 2290 | 0.140 |
Why?
|
| Delivery of Health Care, Integrated | 2 | 2015 | 936 | 0.140 |
Why?
|
| Public-Private Sector Partnerships | 2 | 2014 | 122 | 0.130 |
Why?
|
| Education, Nursing, Diploma Programs | 1 | 2014 | 11 | 0.120 |
Why?
|
| Africa | 1 | 2017 | 705 | 0.120 |
Why?
|
| Delivery of Health Care | 5 | 2016 | 5325 | 0.120 |
Why?
|
| Counterfeit Drugs | 1 | 2013 | 1 | 0.110 |
Why?
|
| Ebolavirus | 1 | 2016 | 251 | 0.110 |
Why?
|
| Circumcision, Male | 1 | 2015 | 148 | 0.110 |
Why?
|
| Contraception Behavior | 1 | 2015 | 180 | 0.110 |
Why?
|
| Negative-Pressure Wound Therapy | 1 | 2015 | 153 | 0.110 |
Why?
|
| Microcephaly | 1 | 2017 | 425 | 0.110 |
Why?
|
| Earthquakes | 1 | 2015 | 186 | 0.110 |
Why?
|
| Case Management | 1 | 2014 | 272 | 0.100 |
Why?
|
| Personnel, Hospital | 1 | 2014 | 285 | 0.100 |
Why?
|
| Family Planning Services | 1 | 2015 | 265 | 0.100 |
Why?
|
| Chemistry, Pharmaceutical | 1 | 2013 | 276 | 0.100 |
Why?
|
| Inservice Training | 1 | 2014 | 375 | 0.100 |
Why?
|
| Community Networks | 1 | 2013 | 201 | 0.100 |
Why?
|
| Health Facilities | 1 | 2016 | 578 | 0.090 |
Why?
|
| Culture | 1 | 2015 | 622 | 0.090 |
Why?
|
| Rural Health Services | 1 | 2014 | 381 | 0.090 |
Why?
|
| Developed Countries | 1 | 2013 | 442 | 0.090 |
Why?
|
| Health Services | 1 | 2015 | 753 | 0.090 |
Why?
|
| Disease Outbreaks | 2 | 2017 | 1758 | 0.090 |
Why?
|
| Tuberculosis, Pulmonary | 2 | 2014 | 831 | 0.080 |
Why?
|
| Disasters | 1 | 2015 | 517 | 0.080 |
Why?
|
| Cholera Vaccines | 1 | 2012 | 262 | 0.080 |
Why?
|
| Child Health Services | 1 | 2014 | 644 | 0.080 |
Why?
|
| HIV Infections | 5 | 2016 | 17165 | 0.080 |
Why?
|
| Diffusion of Innovation | 1 | 2013 | 730 | 0.080 |
Why?
|
| Antiviral Agents | 1 | 2020 | 3061 | 0.080 |
Why?
|
| Health Policy | 3 | 2015 | 2677 | 0.080 |
Why?
|
| Community Health Services | 1 | 2013 | 654 | 0.080 |
Why?
|
| Commerce | 1 | 2013 | 605 | 0.070 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2012 | 592 | 0.070 |
Why?
|
| Vaccines | 1 | 2015 | 832 | 0.070 |
Why?
|
| Drug Industry | 1 | 2013 | 789 | 0.070 |
Why?
|
| Humans | 32 | 2023 | 760621 | 0.070 |
Why?
|
| Attitude to Health | 1 | 2015 | 2029 | 0.070 |
Why?
|
| HIV | 1 | 2013 | 1579 | 0.070 |
Why?
|
| Papillomaviridae | 1 | 2012 | 1117 | 0.070 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2014 | 1894 | 0.060 |
Why?
|
| Cholera | 1 | 2012 | 747 | 0.060 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2016 | 6015 | 0.060 |
Why?
|
| Health Services Research | 1 | 2013 | 1810 | 0.060 |
Why?
|
| Motivation | 1 | 2015 | 1993 | 0.060 |
Why?
|
| Residence Characteristics | 1 | 2015 | 2062 | 0.060 |
Why?
|
| Information Dissemination | 1 | 2013 | 1131 | 0.060 |
Why?
|
| Education, Medical | 1 | 2016 | 1727 | 0.060 |
Why?
|
| Pharmaceutical Preparations | 1 | 2013 | 1091 | 0.060 |
Why?
|
| Organizations | 2 | 2016 | 171 | 0.060 |
Why?
|
| Women's Health | 1 | 2013 | 2056 | 0.060 |
Why?
|
| Medical Oncology | 1 | 2015 | 2313 | 0.050 |
Why?
|
| Glomerular Filtration Rate | 2 | 2022 | 2180 | 0.050 |
Why?
|
| Algorithms | 1 | 2023 | 13981 | 0.050 |
Why?
|
| Wounds and Injuries | 1 | 2015 | 2477 | 0.050 |
Why?
|
| Education, Medical, Graduate | 1 | 2014 | 2363 | 0.050 |
Why?
|
| Child Mortality | 2 | 2014 | 205 | 0.050 |
Why?
|
| Capacity Building | 2 | 2014 | 257 | 0.050 |
Why?
|
| Program Development | 2 | 2015 | 1297 | 0.040 |
Why?
|
| Young Adult | 3 | 2021 | 58741 | 0.040 |
Why?
|
| Pediatrics | 1 | 2013 | 3586 | 0.040 |
Why?
|
| New England | 1 | 2020 | 1050 | 0.040 |
Why?
|
| HIV-1 | 1 | 2014 | 6849 | 0.030 |
Why?
|
| Africa, Western | 1 | 2017 | 159 | 0.030 |
Why?
|
| Creatinine | 1 | 2022 | 1903 | 0.030 |
Why?
|
| Rubella Vaccine | 1 | 2015 | 23 | 0.030 |
Why?
|
| Program Evaluation | 2 | 2015 | 2493 | 0.030 |
Why?
|
| Sierra Leone | 1 | 2016 | 168 | 0.030 |
Why?
|
| Depression | 1 | 2016 | 8044 | 0.030 |
Why?
|
| Vaccines, Combined | 1 | 2015 | 70 | 0.030 |
Why?
|
| Measles Vaccine | 1 | 2015 | 81 | 0.030 |
Why?
|
| Immunocompromised Host | 1 | 2020 | 857 | 0.030 |
Why?
|
| Population Density | 1 | 2015 | 192 | 0.030 |
Why?
|
| Rotavirus Vaccines | 1 | 2015 | 62 | 0.030 |
Why?
|
| Academic Medical Centers | 2 | 2016 | 2754 | 0.030 |
Why?
|
| Sex Education | 1 | 2015 | 92 | 0.030 |
Why?
|
| Nepal | 1 | 2015 | 301 | 0.030 |
Why?
|
| Malaria | 2 | 2014 | 1226 | 0.030 |
Why?
|
| Government Agencies | 1 | 2014 | 160 | 0.030 |
Why?
|
| Drug Prescriptions | 1 | 2023 | 1673 | 0.030 |
Why?
|
| International Educational Exchange | 1 | 2013 | 49 | 0.030 |
Why?
|
| Cost of Illness | 1 | 2023 | 1940 | 0.030 |
Why?
|
| Asia | 1 | 2015 | 620 | 0.030 |
Why?
|
| Child Nutrition Disorders | 1 | 2014 | 150 | 0.030 |
Why?
|
| Models, Psychological | 1 | 2017 | 827 | 0.030 |
Why?
|
| Democratic Republic of the Congo | 1 | 2012 | 86 | 0.030 |
Why?
|
| Breast Feeding | 1 | 2020 | 1355 | 0.030 |
Why?
|
| Africa South of the Sahara | 1 | 2015 | 742 | 0.030 |
Why?
|
| Drug Contamination | 1 | 2013 | 152 | 0.020 |
Why?
|
| Models, Organizational | 1 | 2015 | 545 | 0.020 |
Why?
|
| Pneumococcal Vaccines | 1 | 2015 | 397 | 0.020 |
Why?
|
| Policy Making | 1 | 2015 | 538 | 0.020 |
Why?
|
| Male | 6 | 2021 | 359744 | 0.020 |
Why?
|
| AIDS Serodiagnosis | 1 | 2012 | 216 | 0.020 |
Why?
|
| Nursing Staff, Hospital | 1 | 2014 | 344 | 0.020 |
Why?
|
| Quality Control | 1 | 2013 | 828 | 0.020 |
Why?
|
| Massachusetts | 1 | 2023 | 8803 | 0.020 |
Why?
|
| Haiti | 1 | 2012 | 549 | 0.020 |
Why?
|
| Medical Staff, Hospital | 1 | 2014 | 600 | 0.020 |
Why?
|
| Female | 8 | 2020 | 391270 | 0.020 |
Why?
|
| Gender Identity | 1 | 2015 | 698 | 0.020 |
Why?
|
| Child | 5 | 2016 | 79806 | 0.020 |
Why?
|
| Infant Mortality | 1 | 2014 | 757 | 0.020 |
Why?
|
| Government Regulation | 1 | 2013 | 525 | 0.020 |
Why?
|
| Tanzania | 1 | 2013 | 1383 | 0.020 |
Why?
|
| Diarrhea | 1 | 2014 | 1319 | 0.020 |
Why?
|
| Health Services Needs and Demand | 1 | 2015 | 1399 | 0.020 |
Why?
|
| Health Resources | 1 | 2013 | 935 | 0.020 |
Why?
|
| Leadership | 1 | 2016 | 1371 | 0.020 |
Why?
|
| World Health Organization | 1 | 2013 | 1312 | 0.020 |
Why?
|
| Kidney | 1 | 2022 | 7064 | 0.020 |
Why?
|
| Equipment Design | 1 | 2015 | 3520 | 0.020 |
Why?
|
| Forecasting | 1 | 2015 | 2932 | 0.020 |
Why?
|
| Income | 1 | 2015 | 1875 | 0.020 |
Why?
|
| Neoplasms | 1 | 2015 | 22072 | 0.020 |
Why?
|
| Cross-Sectional Studies | 2 | 2020 | 25942 | 0.020 |
Why?
|
| Primary Prevention | 1 | 2013 | 1207 | 0.020 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2012 | 1348 | 0.020 |
Why?
|
| Interviews as Topic | 1 | 2013 | 2659 | 0.020 |
Why?
|
| Educational Status | 1 | 2013 | 2515 | 0.020 |
Why?
|
| Emergency Medical Services | 1 | 2016 | 1925 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2020 | 8056 | 0.010 |
Why?
|
| Qualitative Research | 1 | 2015 | 2963 | 0.010 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2013 | 2197 | 0.010 |
Why?
|
| Patient Care Team | 1 | 2015 | 2511 | 0.010 |
Why?
|
| Public Health | 1 | 2016 | 2653 | 0.010 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3085 | 0.010 |
Why?
|
| Health Personnel | 1 | 2016 | 3310 | 0.010 |
Why?
|
| Pneumonia | 1 | 2014 | 2131 | 0.010 |
Why?
|
| United States | 3 | 2016 | 72461 | 0.010 |
Why?
|
| Communication | 1 | 2015 | 3849 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2016 | 9287 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2016 | 14660 | 0.010 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2015 | 3986 | 0.010 |
Why?
|
| Tuberculosis | 1 | 2013 | 2001 | 0.010 |
Why?
|
| Anti-HIV Agents | 1 | 2016 | 4491 | 0.010 |
Why?
|
| Parents | 1 | 2013 | 3549 | 0.010 |
Why?
|
| Pregnancy | 1 | 2020 | 29749 | 0.010 |
Why?
|
| Adult | 3 | 2022 | 219994 | 0.010 |
Why?
|
| Palliative Care | 1 | 2013 | 3607 | 0.010 |
Why?
|
| Mass Screening | 1 | 2013 | 5423 | 0.010 |
Why?
|
| Adolescent | 2 | 2016 | 87810 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2012 | 26181 | 0.010 |
Why?
|
| Infant | 1 | 2014 | 36060 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2014 | 42063 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2015 | 58995 | 0.010 |
Why?
|
| Animals | 1 | 2020 | 167963 | 0.000 |
Why?
|
| Aged | 1 | 2015 | 169152 | 0.000 |
Why?
|
| Middle Aged | 1 | 2015 | 220352 | 0.000 |
Why?
|